Wang, Y. et al. Rig-I−/− mice develop colitis associated with downregulation of G alpha i2. Cell Res. 17, 858-868

Department of Medical Genetics, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Cell Research (Impact Factor: 12.41). 11/2007; 17(10):858-68. DOI: 10.1038/cr.2007.81
Source: PubMed


RIG-I (retinoid acid-inducible gene-I), a putative RNA helicase with a cytoplasmic caspase-recruitment domain (CARD), was identified as a pattern-recognition receptor (PRR) that mediates antiviral immunity by inducing type I interferon production. To further study the biological function of RIG-I, we generated Rig-I(-/-) mice through homologous recombination, taking a different strategy to the previously reported strategy. Our Rig-I(-/-) mice are viable and fertile. Histological analysis shows that Rig-I(-/-) mice develop a colitis-like phenotype and increased susceptibility to dextran sulfate sodium-induced colitis. Accordingly, the size and number of Peyer's patches dramatically decreased in mutant mice. The peripheral T-cell subsets in mutant mice are characterized by an increase in effector T cells and a decrease in naive T cells, indicating an important role for Rig-I in the regulation of T-cell activation. It was further found that Rig-I deficiency leads to the downregulation of G protein alpha i2 subunit (G alpha i2) in various tissues, including T and B lymphocytes. By contrast, upregulation of Rig-I in NB4 cells that are treated with ATRA is accompanied by elevated G alpha i2 expression. Moreover, G alpha i2 promoter activity is increased in co-transfected NIH3T3 cells in a Rig-I dose-dependent manner. All these findings suggest that Rig-I has crucial roles in the regulation of G alpha i2 expression and T-cell activation. The development of colitis may be, at least in part, associated with downregulation of G alpha i2 and disturbed T-cell homeostasis.

Download full-text


Available from: Xue-Song Liu, Feb 11, 2015
  • Source
    • "In particular, RIG-I binds multiple sites within the 3′-UTR of the NFKB1 mRNA and this interaction facilitates recruitment of ribosomal proteins to ensure NFKB1 translation [57]. Finally, a role for RIG-I in T-cell activation is supported by one study of RIG-I(−/−) mice, which showed that RIG-I(−/−) mice develop a colitis-like phenotype with decreased numbers of CD44lowCD62Lhigh naïve T-cells, but increased CD44highCD62Llow effector T cells and CD44highCD62Lhigh memory T cells [58]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whole-genome expression profiling has been used to characterize molecular-level differences between psoriasis lesions and normal skin. Pathway analysis, however, is complicated by the fact that expression profiles have been derived from bulk skin biopsies with RNA derived from multiple cell types. We analyzed gene expression across a large sample of psoriatic (PP) and uninvolved/normal (PN) skin biopsies (n = 215 patients). We identified 1975 differentially expressed genes, including 8 associated with psoriasis susceptibility loci. To facilitate pathway analysis, PP versus PN differences in gene expression were analyzed with respect to 235 gene modules, each containing genes with a similar expression pattern in keratinocytes and epidermis. We identified 30 differentially expressed modules (DEMs) biased towards PP-increased or PP-decreased expression. These DEMs were associated with regulatory axes involving cytokines (e.g., IFN-γ, IL-17A, TNF-α), transcription factors (e.g., STAT1, NF-κB, E2F, RUNX1) and chromatin modifiers (SETDB1). We identified an interferon-induced DEM with genes encoding anti-viral proteins (designated "STAT1-57"), which was activated in psoriatic epidermis but repressed following biologic therapy. Genes within this DEM shared a motif near the transcription start site resembling the interferon-stimulated response element (ISRE). We analyzed a large patient cohort and developed a new approach for delineating epidermis-specific pathways and regulatory mechanisms that underlie altered gene expression in psoriasis. Our findings highlight previously unrecognized "transcription circuits" that can provide targets for development of non-systemic therapies.
    PLoS ONE 11/2013; 8(11):e79253. DOI:10.1371/journal.pone.0079253 · 3.23 Impact Factor
  • Source
    • "Interestingly, extracellular RNA is abundantly present in the synovial lining [55], and it remains to be shown whether chemical modifications that protect endogenous RNAs from enzymatic degradation can generate de novo ligands that are able trigger dsRNA sensors in FLS. In line herewith, recent evidence suggests that RIG-I-like helicases are modifiers of sterile inflammation in the mouse colon and brain [56], [57]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: CD55 (decay-accelerating factor) is a complement-regulatory protein highly expressed on fibroblast-like synoviocytes (FLS). CD55 is also a ligand for CD97, an adhesion-type G protein-coupled receptor abundantly present on leukocytes. Little is known regarding the regulation of CD55 expression in FLS. FLS isolated from arthritis patients were stimulated with pro-inflammatory cytokines and Toll-like receptor (TLR) ligands. Transfection with polyinosinic-polycytidylic acid (poly(I:C)) and 5'-triphosphate RNA were used to activate the cytoplasmic double-stranded (ds)RNA sensors melanoma differentiation-associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I). CD55 expression, cell viability, and binding of CD97-loaded beads were quantified by flow cytometry. CD55 was expressed at equal levels on FLS isolated from patients with rheumatoid arthritis (RA), osteoarthritis, psoriatic arthritis and spondyloarthritis. CD55 expression in RA FLS was significantly induced by IL-1β and especially by the TLR3 ligand poly(I:C). Activation of MDA5 and RIG-I also enhanced CD55 expression. Notably, activation of MDA5 dose-dependently induced cell death, while triggering of TLR3 or RIG-I had a minor effect on viability. Upregulation of CD55 enhanced the binding capacity of FLS to CD97-loaded beads, which could be blocked by antibodies against CD55. Activation of dsRNA sensors enhances the expression of CD55 in cultured FLS, which increases the binding to CD97. Our findings suggest that dsRNA promotes the interaction between FLS and CD97-expressing leukocytes.
    PLoS ONE 05/2012; 7(5):e35606. DOI:10.1371/journal.pone.0035606 · 3.23 Impact Factor
  • Source
    • "Two recent studies have further implicated RIG-I in inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis. One study found that 70% of mice lacking RIG-I gene expression developed a colitis-like phenotype that correlates with inflammatory infiltration and severe damage in the mucosa of the colon [49,50]. The RIG-I-deficient mice had decreases in the size and number of Peyer’s patches, with an increased number of apoptotic B220+ cells within the patches. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The RNA helicase family of RIG-I-like receptors (RLRs) is a key component of host defense mechanisms responsible for detecting viruses and triggering innate immune signaling cascades to control viral replication and dissemination. As cytoplasm-based sensors, RLRs recognize foreign RNA in the cell and activate a cascade of antiviral responses including the induction of type I interferons, inflammasome activation, and expression of proinflammatory cytokines and chemokines. This review provides a brief overview of RLR function, ligand interactions, and downstream signaling events with an expanded discussion on the therapeutic potential of targeting RLRs for immune stimulation and treatment of virus infection.
    Viruses 06/2011; 3(6):906-19. DOI:10.3390/v3060906 · 3.35 Impact Factor
Show more